Roundtable Discussion: Utilizing the Most Optimal Analytical Assays to Support Your Exosome Drug Product Release Strategies

Time: 2:30 pm
day: Pre-Conference Focus Day

Details:

• Evaluating conventional and novel instruments to analyze exosomes across ELISA, acoustic Imaging, flow cytometry, and more to confidently select your technology
• Ensuring analytical methods are validating, qualifying, and reproducible to ensure safety and sterility of the exosome product
• One vs multiple potency assays – How to address complex mechanisms of action within the production phase

Speakers:

Ina Sarel Dr. Ina Sarel is a biotechnology executive with over 20 years of experience in product development from discovery and Proof of Concept through pre-clinical and Read more

Kristin Luther Dr. Kristin Luther is the VP of CMC & Analytics at AGS Therapeutics and brings a wealth of first-hand experience, extensive expertise, and a proven Read more